These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 17502120

  • 21. Extracellular acidosis elevates carbonic anhydrase IX in human glioblastoma cells via transcriptional modulation that does not depend on hypoxia.
    Ihnatko R, Kubes M, Takacova M, Sedlakova O, Sedlak J, Pastorek J, Kopacek J, Pastorekova S.
    Int J Oncol; 2006 Oct; 29(4):1025-33. PubMed ID: 16964400
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Selective carbonic anhydrase IX inhibitors based on coumarin scaffold as promising antimetastatic agents: WO2012070024.
    Carradori S.
    Expert Opin Ther Pat; 2013 Oct; 23(6):751-6. PubMed ID: 23387899
    [Abstract] [Full Text] [Related]

  • 24. Carbonic anhydrase inhibitors: transepithelial transport of thioureido sulfonamide inhibitors of the cancer-associated isozyme IX is dependent on efflux transporters.
    Vullo D, Steffansen B, Brodin B, Supuran CT, Scozzafava A, Nielsen CU.
    Bioorg Med Chem; 2006 Apr 01; 14(7):2418-27. PubMed ID: 16321542
    [Abstract] [Full Text] [Related]

  • 25. In vivo imaging and quantification of carbonic anhydrase IX expression as an endogenous biomarker of tumor hypoxia.
    Bao B, Groves K, Zhang J, Handy E, Kennedy P, Cuneo G, Supuran CT, Yared W, Rajopadhye M, Peterson JD.
    PLoS One; 2012 Apr 01; 7(11):e50860. PubMed ID: 23226406
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX.
    Pastorekova S, Casini A, Scozzafava A, Vullo D, Pastorek J, Supuran CT.
    Bioorg Med Chem Lett; 2004 Feb 23; 14(4):869-73. PubMed ID: 15012984
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
    Bache M, Reddemann R, Said HM, Holzhausen HJ, Taubert H, Becker A, Kuhnt T, Hänsgen G, Dunst J, Vordermark D.
    Int J Radiat Oncol Biol Phys; 2006 Dec 01; 66(5):1481-7. PubMed ID: 17056190
    [Abstract] [Full Text] [Related]

  • 32. DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1alpha in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX.
    Kaluzová M, Kaluz S, Lerman MI, Stanbridge EJ.
    Mol Cell Biol; 2004 Jul 01; 24(13):5757-66. PubMed ID: 15199132
    [Abstract] [Full Text] [Related]

  • 33. Expression of carbonic anhydrase IX in craniopharyngiomas.
    Proescholdt M, Merrill M, Stoerr EM, Lohmeier A, Dietmaier W, Brawanski A.
    J Neurosurg; 2011 Oct 01; 115(4):796-801. PubMed ID: 21761968
    [Abstract] [Full Text] [Related]

  • 34. Hypoxia-targeting carbonic anhydrase IX inhibitors by a new series of nitroimidazole-sulfonamides/sulfamides/sulfamates.
    Rami M, Dubois L, Parvathaneni NK, Alterio V, van Kuijk SJ, Monti SM, Lambin P, De Simone G, Supuran CT, Winum JY.
    J Med Chem; 2013 Nov 14; 56(21):8512-20. PubMed ID: 24128000
    [Abstract] [Full Text] [Related]

  • 35. Carbonic anhydrase IX: a new druggable target for the design of antitumor agents.
    Winum JY, Rami M, Scozzafava A, Montero JL, Supuran C.
    Med Res Rev; 2008 May 14; 28(3):445-63. PubMed ID: 17880011
    [Abstract] [Full Text] [Related]

  • 36. Carnosine inhibits carbonic anhydrase IX-mediated extracellular acidosis and suppresses growth of HeLa tumor xenografts.
    Ditte Z, Ditte P, Labudova M, Simko V, Iuliano F, Zatovicova M, Csaderova L, Pastorekova S, Pastorek J.
    BMC Cancer; 2014 May 22; 14():358. PubMed ID: 24886661
    [Abstract] [Full Text] [Related]

  • 37. Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX.
    Alterio V, Vitale RM, Monti SM, Pedone C, Scozzafava A, Cecchi A, De Simone G, Supuran CT.
    J Am Chem Soc; 2006 Jun 28; 128(25):8329-35. PubMed ID: 16787097
    [Abstract] [Full Text] [Related]

  • 38. Designing carbonic anhydrase inhibitors for the treatment of breast cancer.
    Supuran CT, Winum JY.
    Expert Opin Drug Discov; 2015 Jun 28; 10(6):591-7. PubMed ID: 25891195
    [Abstract] [Full Text] [Related]

  • 39. Suppression of carbonic anhydrase IX leads to aberrant focal adhesion and decreased invasion of tumor cells.
    Radvak P, Repic M, Svastova E, Takacova M, Csaderova L, Strnad H, Pastorek J, Pastorekova S, Kopacek J.
    Oncol Rep; 2013 Mar 28; 29(3):1147-53. PubMed ID: 23291973
    [Abstract] [Full Text] [Related]

  • 40. Intact intracellular tail is critical for proper functioning of the tumor-associated, hypoxia-regulated carbonic anhydrase IX.
    Hulikova A, Zatovicova M, Svastova E, Ditte P, Brasseur R, Kettmann R, Supuran CT, Kopacek J, Pastorek J, Pastorekova S.
    FEBS Lett; 2009 Nov 19; 583(22):3563-8. PubMed ID: 19861127
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.